title: Reoperative management of intracranial aneurysms.
abstract: Nineteen patients underwent 20 operative procedures for the treatment of recurrent or residual aneurysms. There were 13 small, three large, and four giant lesions; with one exception, all were in the anterior circulation. Five individuals presented with recurrent subarachnoid hemorrhage, six were referred for symptoms of mass effect, and nine were known to have had inadequate treatment at the time of the initial operative procedure. The average time interval from initial treatment to either recurrent subarachnoid hemorrhage or compressive effects was 10.5 and 9.75 years, respectively. No deaths resulted from the reoperative procedures. Two patients suffered moderate disability and one had severe disability. Malpositioned or slipped clips, intraoperative rupture, and inadequate exposure were responsible for 75% of the initial operative failures. The technical difficulty of the reoperative procedure correlated with the length of time between initial and reoperative treatment, the presence of clips and coating agents, and the complexity of the lesion. A classification scheme for preoperative planning and case selection is proposed based on the technical adjuncts required for reoperative aneurysm procedures.
authors.affiliation: Department of Neurosurgery, University of Southern California School of Medicine, Los Angeles, USA.
authors.forename: S L
authors.initials: SL
authors.lastname: Giannotta
authors.forename: N S
authors.initials: NS
authors.lastname: Litofsky
mesh_terms: D017542:Aneurysm, Ruptured / Q000209:etiology / Q000601:surgery; D001921:Brain; D004868:Equipment Failure; D005547:Foreign Bodies / Q000150:complications; D005548:Foreign-Body Migration / Q000150:complications; D006801:Humans; D002532:Intracranial Aneurysm / Q000601:surgery*; D012008:Recurrence; D012086:Reoperation / Q000009:adverse effects / Q000145:classification; D012422:Rupture, Spontaneous; D013345:Subarachnoid Hemorrhage / Q000209:etiology / Q000601:surgery*; D013525:Surgical Instruments / Q000009:adverse effects; D014014:Tissue Adhesives / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D014014:Tissue Adhesives